162 related articles for article (PubMed ID: 10365287)
1. The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
Linder R; Oldgren J; Egberg N; Grip L; Larson G; Siegbahn A; Wallentin L
Eur Heart J; 1999 Apr; 20(7):506-18. PubMed ID: 10365287
[TBL] [Abstract][Full Text] [Related]
2. A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group.
Eur Heart J; 1997 Sep; 18(9):1416-25. PubMed ID: 9458447
[TBL] [Abstract][Full Text] [Related]
3. Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.
Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
Eur Heart J; 1999 Nov; 20(22):1657-66. PubMed ID: 10543929
[TBL] [Abstract][Full Text] [Related]
4. Thrombin inhibition with inogatran for unstable angina pectoris: evidence for reactivated ischaemia after cessation of short-term treatment.
Andersen K; Dellborg M; Emanuelsson H; Grip L; Swedberg K
Coron Artery Dis; 1996 Sep; 7(9):673-81. PubMed ID: 8950498
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
6. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
Oldgren J; Siegbahn A; Grip L; Linder R; Thygesen K; Wallentin L
Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
[TBL] [Abstract][Full Text] [Related]
7. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
8. Heparin is more effective than inogatran, a low-molecular weight thrombin inhibitor in suppressing ischemia and recurrent angina in unstable coronary disease. Thrombin Inhibition in Myocardial Ischemia (TRIM) Study Group.
Andersen K; Dellborg M
Am J Cardiol; 1998 Apr; 81(8):939-44. PubMed ID: 9576150
[TBL] [Abstract][Full Text] [Related]
9. Coagulation activity and clinical outcome in unstable coronary artery disease.
Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1059-64. PubMed ID: 11397720
[TBL] [Abstract][Full Text] [Related]
10. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
[TBL] [Abstract][Full Text] [Related]
12. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
[TBL] [Abstract][Full Text] [Related]
13. Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis.
Chen LY; Nichols WW; Mattsson C; Teger-Nilson AC; Wallin R; Saldeen TG; Mehta JL
Cardiovasc Res; 1995 Dec; 30(6):866-74. PubMed ID: 8746200
[TBL] [Abstract][Full Text] [Related]
14. Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease.
Oldgren J; Wallentin L; Grip L; Linder R; Nørgaard BL; Siegbahn A
Eur Heart J; 2003 Jan; 24(1):86-93. PubMed ID: 12559940
[TBL] [Abstract][Full Text] [Related]
15. Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis.
Chen L; Nichols WW; Mattsson C; Teger-Nilsson AC; Saldeen TG; Mehta JL
J Pharmacol Exp Ther; 1996 Jun; 277(3):1276-83. PubMed ID: 8667188
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina.
Klootwijk P; Lenderink T; Meij S; Boersma H; Melkert R; Umans VA; Stibbe J; Müller EJ; Poortermans KJ; Deckers JW; Simoons ML
Eur Heart J; 1999 Aug; 20(15):1101-11. PubMed ID: 10413640
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic activity of inogatran, a new low-molecular-weight inhibitor of thrombin, in a closed-chest porcine model of coronary artery thrombosis.
Uriuda Y; Wang QD; Grip L; Rydén L; Sjöquist PO; Mattsson C
Cardiovasc Res; 1996 Aug; 32(2):320-7. PubMed ID: 8796119
[TBL] [Abstract][Full Text] [Related]
18. Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential.
Becker RC; Spencer FA; Li Y; Ball SP; Ma Y; Hurley T; Hebert J
J Am Coll Cardiol; 1999 Oct; 34(4):1020-7. PubMed ID: 10520784
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease.
Ernofsson M; Strekerud F; Toss H; Abildgaard U; Wallentin L; Siegbahn A
Thromb Haemost; 1998 Mar; 79(3):491-4. PubMed ID: 9531028
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
Mombelli G; Marchetti O; Haeberli A; Straub PW
Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
